What is Neurogram?
Neurogram operates at the intersection of artificial intelligence and clinical neurology, providing a sophisticated cloud-based platform designed to manage, analyze, and report electroencephalogram (EEG) data. The company addresses a significant pain point in healthcare by automating the labor-intensive processes of exam uploads, visualization, and report generation. By integrating advanced analytical tools into a secure, centralized environment, Neurogram enables healthcare professionals to enhance diagnostic accuracy while simultaneously streamlining clinical workflows. This platform serves as a vital infrastructure layer for both research institutions and clinical care providers, facilitating more efficient data handling and improved patient outcomes through high-fidelity neurological insights.
How much funding has Neurogram raised?
Neurogram has raised a total of $4.4M across 2 funding rounds:
Angel/Pre-Seed
$1.4M
Seed
$3M
Angel/Pre-Seed (2022): $1.4M with participation from Starship Ventures
Seed (2025): $3M led by Headline
Key Investors in Neurogram
Headline
Headline is a global venture capital firm that partners with high-growth technology teams, leveraging its international presence to lead investment rounds across various stages of company development.
Starship Ventures
Starship Ventures is a deep tech-focused VC firm that supports contrarian founders building transformative solutions in AI, robotics, and biotech to advance human agency.
What's next for Neurogram?
With the successful closure of this major strategic investment, Neurogram is poised to scale its operations and expand its market footprint. The company's roadmap likely involves deepening its AI capabilities to further refine diagnostic precision and expanding its cloud infrastructure to support larger enterprise clients. As the firm matures, the focus will shift toward establishing deeper integrations with existing hospital information systems and electronic health records, ensuring that its EEG management platform becomes an indispensable tool for neurological departments globally. The current capital position provides the necessary runway to pursue these aggressive growth objectives while maintaining the high security and compliance standards required in the medical technology sector.
See full Neurogram company page
